Further Data Against the Use of Cyproterone Acetate in Gender-Affirming Hormone Therapy Regimens - Top-Institutions - MDSpire

Further Data Against the Use of Cyproterone Acetate in Gender-Affirming Hormone Therapy Regimens

  • By

  • Daniel J Slack

  • Joshua D Safer

  • October 16, 2024

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Fenway Institute
    Fenway Institute

    Boston, MA

    Key Differentiators

    • Transgender Medicine
    • Endocrinology
    • LGBTQ+ Health Research

  • #2

    Center of Excellence for Transgender Health, University of California San Francisco
    Center of Excellence for Transgender Health, University of California San Francisco

    San Francisco, CA

    Key Differentiators

    • Transgender Medicine
    • Endocrinology
    • Public Health

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Transgender Medicine
    • Clinical Research

  • #4

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center

    Nashville, TN

    Key Differentiators

    • Endocrinology
    • Transgender Health
    • Clinical Pharmacology

  • #5

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Endocrinology
    • Transgender Medicine
    • LGBTQ+ Health

Original Source(s)

Further Data Against the Use of Cyproterone Acetate in Gender-Affirming Hormone Therapy Regimens

  • by Daniel J Slack, Joshua D Safer

  • October 16, 2024

Related Content

Cardiovascular and Autonomic Responses to Incremental Exercise in Adolescents with Type 1 Diabetes

Child Opportunity Index and Prevalence of Obesity and Hypertension in Adolescents with Congenital Heart Disease

Frequency of Hyperinsulinemia and Its Relationship with Adiposity and Body Composition in Adolescents and Young Adults Aged 16-25 in Mumbai